ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Covid-19 Rapid Antigen Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-3D10033
Home | Market Reports | Health| Medical Devices & Equipment
Global Covid 19 Rapid Antigen Market Research Report 2022
BUY CHAPTERS

Global Covid-19 Rapid Antigen Market Research Report 2025

Code: QYRE-Auto-3D10033
Report
March 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Access Bio
BD
Quidel
Fujirebio
Ellume
Orasure Technologies
Celltrion Healthcare
IHealth Labs
Hangzhou AllTest Biotech
SD Biosensor
MP Biomedical
CTK Biotech
BIOHIT Healthcare
Assure Tech
Hangzhou Clongene Biotech
Clip Health
Salofa Oy
Novegent
Guangzhou Decheng Biotechnology
Jiangsu Well Biotech
Hangzhou Laihe Biotech
Innovation Scientific
ACON Biotech
Hangzhou Testsea Biotechnology

Covid-19 Rapid Antigen Market

The global market for Covid-19 Rapid Antigen was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Covid-19 Rapid Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Covid-19 Rapid Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Covid-19 Rapid Antigen include Abbott, Access Bio, BD, Quidel, Fujirebio, Ellume, OraSure Technologies, Clip Health, Celltrion Healthcare, Salofa Oy, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Covid-19 Rapid Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Rapid Antigen.
The Covid-19 Rapid Antigen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Covid-19 Rapid Antigen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Rapid Antigen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Covid-19 Rapid Antigen Market Report

Report Metric Details
Report Name Covid-19 Rapid Antigen Market
Segment by Type
  • Nasal Swab
  • Oral Fluid/Saliva
Segment by Application
  • Hospitals
  • Scientific Research
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Access Bio, BD, Quidel, Fujirebio, Ellume, OraSure Technologies, Clip Health, Celltrion Healthcare, Salofa Oy, iHealth Labs, Novegent, Hangzhou Alltest Biotech, Guangzhou Decheng Biotechnology, SD Biosensor, MP Biomedical, Jiangsu Well Biotech, CTK Biotech, Hangzhou Laihe Biotech, Innovation Scientific, Biohit Healthcare, ACON Biotech, Assure Tech, Hangzhou Clongene Biotech, Hangzhou Testsea Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Covid-19 Rapid Antigen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Covid-19 Rapid Antigen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Covid-19 Rapid Antigen Market report?

Ans: The main players in the Covid-19 Rapid Antigen Market are Abbott, Access Bio, BD, Quidel, Fujirebio, Ellume, OraSure Technologies, Clip Health, Celltrion Healthcare, Salofa Oy, iHealth Labs, Novegent, Hangzhou Alltest Biotech, Guangzhou Decheng Biotechnology, SD Biosensor, MP Biomedical, Jiangsu Well Biotech, CTK Biotech, Hangzhou Laihe Biotech, Innovation Scientific, Biohit Healthcare, ACON Biotech, Assure Tech, Hangzhou Clongene Biotech, Hangzhou Testsea Biotechnology

What are the Application segmentation covered in the Covid-19 Rapid Antigen Market report?

Ans: The Applications covered in the Covid-19 Rapid Antigen Market report are Hospitals, Scientific Research

What are the Type segmentation covered in the Covid-19 Rapid Antigen Market report?

Ans: The Types covered in the Covid-19 Rapid Antigen Market report are Nasal Swab, Oral Fluid/Saliva

1 Covid-19 Rapid Antigen Market Overview
1.1 Product Definition
1.2 Covid-19 Rapid Antigen by Type
1.2.1 Global Covid-19 Rapid Antigen Market Value Comparison by Type (2024 VS 2031)
1.2.2 Nasal Swab
1.2.3 Oral Fluid/Saliva
1.3 Covid-19 Rapid Antigen by Application
1.3.1 Global Covid-19 Rapid Antigen Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Scientific Research
1.4 Global Covid-19 Rapid Antigen Market Size Estimates and Forecasts
1.4.1 Global Covid-19 Rapid Antigen Revenue 2020-2031
1.4.2 Global Covid-19 Rapid Antigen Sales 2020-2031
1.4.3 Global Covid-19 Rapid Antigen Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Covid-19 Rapid Antigen Market Competition by Manufacturers
2.1 Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2020-2025)
2.2 Global Covid-19 Rapid Antigen Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Covid-19 Rapid Antigen Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Covid-19 Rapid Antigen, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Covid-19 Rapid Antigen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Covid-19 Rapid Antigen, Product Type & Application
2.7 Global Key Manufacturers of Covid-19 Rapid Antigen, Date of Enter into This Industry
2.8 Global Covid-19 Rapid Antigen Market Competitive Situation and Trends
2.8.1 Global Covid-19 Rapid Antigen Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Covid-19 Rapid Antigen Players Market Share by Revenue
2.8.3 Global Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Covid-19 Rapid Antigen Market Scenario by Region
3.1 Global Covid-19 Rapid Antigen Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Covid-19 Rapid Antigen Sales by Region: 2020-2031
3.2.1 Global Covid-19 Rapid Antigen Sales by Region: 2020-2025
3.2.2 Global Covid-19 Rapid Antigen Sales by Region: 2026-2031
3.3 Global Covid-19 Rapid Antigen Revenue by Region: 2020-2031
3.3.1 Global Covid-19 Rapid Antigen Revenue by Region: 2020-2025
3.3.2 Global Covid-19 Rapid Antigen Revenue by Region: 2026-2031
3.4 North America Covid-19 Rapid Antigen Market Facts & Figures by Country
3.4.1 North America Covid-19 Rapid Antigen Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Covid-19 Rapid Antigen Sales by Country (2020-2031)
3.4.3 North America Covid-19 Rapid Antigen Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Covid-19 Rapid Antigen Market Facts & Figures by Country
3.5.1 Europe Covid-19 Rapid Antigen Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Covid-19 Rapid Antigen Sales by Country (2020-2031)
3.5.3 Europe Covid-19 Rapid Antigen Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Covid-19 Rapid Antigen Market Facts & Figures by Region
3.6.1 Asia Pacific Covid-19 Rapid Antigen Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Covid-19 Rapid Antigen Sales by Region (2020-2031)
3.6.3 Asia Pacific Covid-19 Rapid Antigen Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Covid-19 Rapid Antigen Market Facts & Figures by Country
3.7.1 Latin America Covid-19 Rapid Antigen Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Covid-19 Rapid Antigen Sales by Country (2020-2031)
3.7.3 Latin America Covid-19 Rapid Antigen Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Covid-19 Rapid Antigen Market Facts & Figures by Country
3.8.1 Middle East and Africa Covid-19 Rapid Antigen Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Covid-19 Rapid Antigen Sales by Country (2020-2031)
3.8.3 Middle East and Africa Covid-19 Rapid Antigen Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Covid-19 Rapid Antigen Sales by Type (2020-2031)
4.1.1 Global Covid-19 Rapid Antigen Sales by Type (2020-2025)
4.1.2 Global Covid-19 Rapid Antigen Sales by Type (2026-2031)
4.1.3 Global Covid-19 Rapid Antigen Sales Market Share by Type (2020-2031)
4.2 Global Covid-19 Rapid Antigen Revenue by Type (2020-2031)
4.2.1 Global Covid-19 Rapid Antigen Revenue by Type (2020-2025)
4.2.2 Global Covid-19 Rapid Antigen Revenue by Type (2026-2031)
4.2.3 Global Covid-19 Rapid Antigen Revenue Market Share by Type (2020-2031)
4.3 Global Covid-19 Rapid Antigen Price by Type (2020-2031)
5 Segment by Application
5.1 Global Covid-19 Rapid Antigen Sales by Application (2020-2031)
5.1.1 Global Covid-19 Rapid Antigen Sales by Application (2020-2025)
5.1.2 Global Covid-19 Rapid Antigen Sales by Application (2026-2031)
5.1.3 Global Covid-19 Rapid Antigen Sales Market Share by Application (2020-2031)
5.2 Global Covid-19 Rapid Antigen Revenue by Application (2020-2031)
5.2.1 Global Covid-19 Rapid Antigen Revenue by Application (2020-2025)
5.2.2 Global Covid-19 Rapid Antigen Revenue by Application (2026-2031)
5.2.3 Global Covid-19 Rapid Antigen Revenue Market Share by Application (2020-2031)
5.3 Global Covid-19 Rapid Antigen Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Covid-19 Rapid Antigen Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Access Bio
6.2.1 Access Bio Company Information
6.2.2 Access Bio Description and Business Overview
6.2.3 Access Bio Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Access Bio Covid-19 Rapid Antigen Product Portfolio
6.2.5 Access Bio Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Covid-19 Rapid Antigen Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Quidel
6.4.1 Quidel Company Information
6.4.2 Quidel Description and Business Overview
6.4.3 Quidel Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Quidel Covid-19 Rapid Antigen Product Portfolio
6.4.5 Quidel Recent Developments/Updates
6.5 Fujirebio
6.5.1 Fujirebio Company Information
6.5.2 Fujirebio Description and Business Overview
6.5.3 Fujirebio Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Fujirebio Covid-19 Rapid Antigen Product Portfolio
6.5.5 Fujirebio Recent Developments/Updates
6.6 Ellume
6.6.1 Ellume Company Information
6.6.2 Ellume Description and Business Overview
6.6.3 Ellume Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ellume Covid-19 Rapid Antigen Product Portfolio
6.6.5 Ellume Recent Developments/Updates
6.7 OraSure Technologies
6.7.1 OraSure Technologies Company Information
6.7.2 OraSure Technologies Description and Business Overview
6.7.3 OraSure Technologies Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OraSure Technologies Covid-19 Rapid Antigen Product Portfolio
6.7.5 OraSure Technologies Recent Developments/Updates
6.8 Clip Health
6.8.1 Clip Health Company Information
6.8.2 Clip Health Description and Business Overview
6.8.3 Clip Health Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Clip Health Covid-19 Rapid Antigen Product Portfolio
6.8.5 Clip Health Recent Developments/Updates
6.9 Celltrion Healthcare
6.9.1 Celltrion Healthcare Company Information
6.9.2 Celltrion Healthcare Description and Business Overview
6.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Celltrion Healthcare Covid-19 Rapid Antigen Product Portfolio
6.9.5 Celltrion Healthcare Recent Developments/Updates
6.10 Salofa Oy
6.10.1 Salofa Oy Company Information
6.10.2 Salofa Oy Description and Business Overview
6.10.3 Salofa Oy Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Salofa Oy Covid-19 Rapid Antigen Product Portfolio
6.10.5 Salofa Oy Recent Developments/Updates
6.11 iHealth Labs
6.11.1 iHealth Labs Company Information
6.11.2 iHealth Labs Description and Business Overview
6.11.3 iHealth Labs Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.11.4 iHealth Labs Covid-19 Rapid Antigen Product Portfolio
6.11.5 iHealth Labs Recent Developments/Updates
6.12 Novegent
6.12.1 Novegent Company Information
6.12.2 Novegent Description and Business Overview
6.12.3 Novegent Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Novegent Covid-19 Rapid Antigen Product Portfolio
6.12.5 Novegent Recent Developments/Updates
6.13 Hangzhou Alltest Biotech
6.13.1 Hangzhou Alltest Biotech Company Information
6.13.2 Hangzhou Alltest Biotech Description and Business Overview
6.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Portfolio
6.13.5 Hangzhou Alltest Biotech Recent Developments/Updates
6.14 Guangzhou Decheng Biotechnology
6.14.1 Guangzhou Decheng Biotechnology Company Information
6.14.2 Guangzhou Decheng Biotechnology Description and Business Overview
6.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Portfolio
6.14.5 Guangzhou Decheng Biotechnology Recent Developments/Updates
6.15 SD Biosensor
6.15.1 SD Biosensor Company Information
6.15.2 SD Biosensor Description and Business Overview
6.15.3 SD Biosensor Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.15.4 SD Biosensor Covid-19 Rapid Antigen Product Portfolio
6.15.5 SD Biosensor Recent Developments/Updates
6.16 MP Biomedical
6.16.1 MP Biomedical Company Information
6.16.2 MP Biomedical Description and Business Overview
6.16.3 MP Biomedical Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.16.4 MP Biomedical Covid-19 Rapid Antigen Product Portfolio
6.16.5 MP Biomedical Recent Developments/Updates
6.17 Jiangsu Well Biotech
6.17.1 Jiangsu Well Biotech Company Information
6.17.2 Jiangsu Well Biotech Description and Business Overview
6.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Portfolio
6.17.5 Jiangsu Well Biotech Recent Developments/Updates
6.18 CTK Biotech
6.18.1 CTK Biotech Company Information
6.18.2 CTK Biotech Description and Business Overview
6.18.3 CTK Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.18.4 CTK Biotech Covid-19 Rapid Antigen Product Portfolio
6.18.5 CTK Biotech Recent Developments/Updates
6.19 Hangzhou Laihe Biotech
6.19.1 Hangzhou Laihe Biotech Company Information
6.19.2 Hangzhou Laihe Biotech Description and Business Overview
6.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Portfolio
6.19.5 Hangzhou Laihe Biotech Recent Developments/Updates
6.20 Innovation Scientific
6.20.1 Innovation Scientific Company Information
6.20.2 Innovation Scientific Description and Business Overview
6.20.3 Innovation Scientific Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Innovation Scientific Covid-19 Rapid Antigen Product Portfolio
6.20.5 Innovation Scientific Recent Developments/Updates
6.21 Biohit Healthcare
6.21.1 Biohit Healthcare Company Information
6.21.2 Biohit Healthcare Description and Business Overview
6.21.3 Biohit Healthcare Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Biohit Healthcare Covid-19 Rapid Antigen Product Portfolio
6.21.5 Biohit Healthcare Recent Developments/Updates
6.22 ACON Biotech
6.22.1 ACON Biotech Company Information
6.22.2 ACON Biotech Description and Business Overview
6.22.3 ACON Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.22.4 ACON Biotech Covid-19 Rapid Antigen Product Portfolio
6.22.5 ACON Biotech Recent Developments/Updates
6.23 Assure Tech
6.23.1 Assure Tech Company Information
6.23.2 Assure Tech Description and Business Overview
6.23.3 Assure Tech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Assure Tech Covid-19 Rapid Antigen Product Portfolio
6.23.5 Assure Tech Recent Developments/Updates
6.24 Hangzhou Clongene Biotech
6.24.1 Hangzhou Clongene Biotech Company Information
6.24.2 Hangzhou Clongene Biotech Description and Business Overview
6.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Portfolio
6.24.5 Hangzhou Clongene Biotech Recent Developments/Updates
6.25 Hangzhou Testsea Biotechnology
6.25.1 Hangzhou Testsea Biotechnology Company Information
6.25.2 Hangzhou Testsea Biotechnology Description and Business Overview
6.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Portfolio
6.25.5 Hangzhou Testsea Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Covid-19 Rapid Antigen Industry Chain Analysis
7.2 Covid-19 Rapid Antigen Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Covid-19 Rapid Antigen Production Mode & Process Analysis
7.4 Covid-19 Rapid Antigen Sales and Marketing
7.4.1 Covid-19 Rapid Antigen Sales Channels
7.4.2 Covid-19 Rapid Antigen Distributors
7.5 Covid-19 Rapid Antigen Customer Analysis
8 Covid-19 Rapid Antigen Market Dynamics
8.1 Covid-19 Rapid Antigen Industry Trends
8.2 Covid-19 Rapid Antigen Market Drivers
8.3 Covid-19 Rapid Antigen Market Challenges
8.4 Covid-19 Rapid Antigen Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott
Access Bio
BD
Quidel
Fujirebio
Ellume
Orasure Technologies
Celltrion Healthcare
IHealth Labs
Hangzhou AllTest Biotech
SD Biosensor
MP Biomedical
CTK Biotech
BIOHIT Healthcare
Assure Tech
Hangzhou Clongene Biotech
Clip Health
Salofa Oy
Novegent
Guangzhou Decheng Biotechnology
Jiangsu Well Biotech
Hangzhou Laihe Biotech
Innovation Scientific
ACON Biotech
Hangzhou Testsea Biotechnology
List of Tables
 Table 1. Global Covid-19 Rapid Antigen Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Covid-19 Rapid Antigen Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Covid-19 Rapid Antigen Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Covid-19 Rapid Antigen Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Covid-19 Rapid Antigen Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Covid-19 Rapid Antigen, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Covid-19 Rapid Antigen, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Covid-19 Rapid Antigen, Product Type & Application
 Table 12. Global Key Manufacturers of Covid-19 Rapid Antigen, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Covid-19 Rapid Antigen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Antigen as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Covid-19 Rapid Antigen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Covid-19 Rapid Antigen Sales by Region (2020-2025) & (K Units)
 Table 18. Global Covid-19 Rapid Antigen Sales Market Share by Region (2020-2025)
 Table 19. Global Covid-19 Rapid Antigen Sales by Region (2026-2031) & (K Units)
 Table 20. Global Covid-19 Rapid Antigen Sales Market Share by Region (2026-2031)
 Table 21. Global Covid-19 Rapid Antigen Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Covid-19 Rapid Antigen Revenue Market Share by Region (2020-2025)
 Table 23. Global Covid-19 Rapid Antigen Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Covid-19 Rapid Antigen Revenue Market Share by Region (2026-2031)
 Table 25. North America Covid-19 Rapid Antigen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
 Table 27. North America Covid-19 Rapid Antigen Sales by Country (2026-2031) & (K Units)
 Table 28. North America Covid-19 Rapid Antigen Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Covid-19 Rapid Antigen Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Covid-19 Rapid Antigen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Covid-19 Rapid Antigen Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Covid-19 Rapid Antigen Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Covid-19 Rapid Antigen Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Covid-19 Rapid Antigen Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Covid-19 Rapid Antigen Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Covid-19 Rapid Antigen Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Covid-19 Rapid Antigen Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Covid-19 Rapid Antigen Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Covid-19 Rapid Antigen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Covid-19 Rapid Antigen Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Covid-19 Rapid Antigen Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Covid-19 Rapid Antigen Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Covid-19 Rapid Antigen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Covid-19 Rapid Antigen Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Covid-19 Rapid Antigen Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Covid-19 Rapid Antigen Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Covid-19 Rapid Antigen Sales (K Units) by Type (2020-2025)
 Table 51. Global Covid-19 Rapid Antigen Sales (K Units) by Type (2026-2031)
 Table 52. Global Covid-19 Rapid Antigen Sales Market Share by Type (2020-2025)
 Table 53. Global Covid-19 Rapid Antigen Sales Market Share by Type (2026-2031)
 Table 54. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Covid-19 Rapid Antigen Revenue Market Share by Type (2020-2025)
 Table 57. Global Covid-19 Rapid Antigen Revenue Market Share by Type (2026-2031)
 Table 58. Global Covid-19 Rapid Antigen Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Covid-19 Rapid Antigen Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Covid-19 Rapid Antigen Sales (K Units) by Application (2020-2025)
 Table 61. Global Covid-19 Rapid Antigen Sales (K Units) by Application (2026-2031)
 Table 62. Global Covid-19 Rapid Antigen Sales Market Share by Application (2020-2025)
 Table 63. Global Covid-19 Rapid Antigen Sales Market Share by Application (2026-2031)
 Table 64. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Covid-19 Rapid Antigen Revenue Market Share by Application (2020-2025)
 Table 67. Global Covid-19 Rapid Antigen Revenue Market Share by Application (2026-2031)
 Table 68. Global Covid-19 Rapid Antigen Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Covid-19 Rapid Antigen Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Covid-19 Rapid Antigen Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Access Bio Company Information
 Table 76. Access Bio Description and Business Overview
 Table 77. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Access Bio Covid-19 Rapid Antigen Product
 Table 79. Access Bio Recent Developments/Updates
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BD Covid-19 Rapid Antigen Product
 Table 84. BD Recent Developments/Updates
 Table 85. Quidel Company Information
 Table 86. Quidel Description and Business Overview
 Table 87. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Quidel Covid-19 Rapid Antigen Product
 Table 89. Quidel Recent Developments/Updates
 Table 90. Fujirebio Company Information
 Table 91. Fujirebio Description and Business Overview
 Table 92. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Fujirebio Covid-19 Rapid Antigen Product
 Table 94. Fujirebio Recent Developments/Updates
 Table 95. Ellume Company Information
 Table 96. Ellume Description and Business Overview
 Table 97. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Ellume Covid-19 Rapid Antigen Product
 Table 99. Ellume Recent Developments/Updates
 Table 100. OraSure Technologies Company Information
 Table 101. OraSure Technologies Description and Business Overview
 Table 102. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. OraSure Technologies Covid-19 Rapid Antigen Product
 Table 104. OraSure Technologies Recent Developments/Updates
 Table 105. Clip Health Company Information
 Table 106. Clip Health Description and Business Overview
 Table 107. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Clip Health Covid-19 Rapid Antigen Product
 Table 109. Clip Health Recent Developments/Updates
 Table 110. Celltrion Healthcare Company Information
 Table 111. Celltrion Healthcare Description and Business Overview
 Table 112. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Celltrion Healthcare Covid-19 Rapid Antigen Product
 Table 114. Celltrion Healthcare Recent Developments/Updates
 Table 115. Salofa Oy Company Information
 Table 116. Salofa Oy Description and Business Overview
 Table 117. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Salofa Oy Covid-19 Rapid Antigen Product
 Table 119. Salofa Oy Recent Developments/Updates
 Table 120. iHealth Labs Company Information
 Table 121. iHealth Labs Description and Business Overview
 Table 122. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. iHealth Labs Covid-19 Rapid Antigen Product
 Table 124. iHealth Labs Recent Developments/Updates
 Table 125. Novegent Company Information
 Table 126. Novegent Description and Business Overview
 Table 127. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Novegent Covid-19 Rapid Antigen Product
 Table 129. Novegent Recent Developments/Updates
 Table 130. Hangzhou Alltest Biotech Company Information
 Table 131. Hangzhou Alltest Biotech Description and Business Overview
 Table 132. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product
 Table 134. Hangzhou Alltest Biotech Recent Developments/Updates
 Table 135. Guangzhou Decheng Biotechnology Company Information
 Table 136. Guangzhou Decheng Biotechnology Description and Business Overview
 Table 137. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product
 Table 139. Guangzhou Decheng Biotechnology Recent Developments/Updates
 Table 140. SD Biosensor Company Information
 Table 141. SD Biosensor Description and Business Overview
 Table 142. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. SD Biosensor Covid-19 Rapid Antigen Product
 Table 144. SD Biosensor Recent Developments/Updates
 Table 145. MP Biomedical Company Information
 Table 146. MP Biomedical Description and Business Overview
 Table 147. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. MP Biomedical Covid-19 Rapid Antigen Product
 Table 149. MP Biomedical Recent Developments/Updates
 Table 150. Jiangsu Well Biotech Company Information
 Table 151. Jiangsu Well Biotech Description and Business Overview
 Table 152. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Jiangsu Well Biotech Covid-19 Rapid Antigen Product
 Table 154. Jiangsu Well Biotech Recent Developments/Updates
 Table 155. CTK Biotech Company Information
 Table 156. CTK Biotech Description and Business Overview
 Table 157. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. CTK Biotech Covid-19 Rapid Antigen Product
 Table 159. CTK Biotech Recent Developments/Updates
 Table 160. Hangzhou Laihe Biotech Company Information
 Table 161. Hangzhou Laihe Biotech Description and Business Overview
 Table 162. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product
 Table 164. Hangzhou Laihe Biotech Recent Developments/Updates
 Table 165. Innovation Scientific Company Information
 Table 166. Innovation Scientific Description and Business Overview
 Table 167. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Innovation Scientific Covid-19 Rapid Antigen Product
 Table 169. Innovation Scientific Recent Developments/Updates
 Table 170. Biohit Healthcare Company Information
 Table 171. Biohit Healthcare Description and Business Overview
 Table 172. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Biohit Healthcare Covid-19 Rapid Antigen Product
 Table 174. Biohit Healthcare Recent Developments/Updates
 Table 175. ACON Biotech Company Information
 Table 176. ACON Biotech Description and Business Overview
 Table 177. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. ACON Biotech Covid-19 Rapid Antigen Product
 Table 179. ACON Biotech Recent Developments/Updates
 Table 180. Assure Tech Company Information
 Table 181. Assure Tech Description and Business Overview
 Table 182. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Assure Tech Covid-19 Rapid Antigen Product
 Table 184. Assure Tech Recent Developments/Updates
 Table 185. Hangzhou Clongene Biotech Company Information
 Table 186. Hangzhou Clongene Biotech Description and Business Overview
 Table 187. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product
 Table 189. Hangzhou Clongene Biotech Recent Developments/Updates
 Table 190. Hangzhou Testsea Biotechnology Company Information
 Table 191. Hangzhou Testsea Biotechnology Description and Business Overview
 Table 192. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product
 Table 194. Hangzhou Testsea Biotechnology Recent Developments/Updates
 Table 195. Key Raw Materials Lists
 Table 196. Raw Materials Key Suppliers Lists
 Table 197. Covid-19 Rapid Antigen Distributors List
 Table 198. Covid-19 Rapid Antigen Customers List
 Table 199. Covid-19 Rapid Antigen Market Trends
 Table 200. Covid-19 Rapid Antigen Market Drivers
 Table 201. Covid-19 Rapid Antigen Market Challenges
 Table 202. Covid-19 Rapid Antigen Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Covid-19 Rapid Antigen
 Figure 2. Global Covid-19 Rapid Antigen Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Covid-19 Rapid Antigen Market Share by Type: 2024 & 2031
 Figure 4. Nasal Swab Product Picture
 Figure 5. Oral Fluid/Saliva Product Picture
 Figure 6. Global Covid-19 Rapid Antigen Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Covid-19 Rapid Antigen Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Scientific Research
 Figure 10. Global Covid-19 Rapid Antigen Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Covid-19 Rapid Antigen Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Covid-19 Rapid Antigen Sales (2020-2031) & (K Units)
 Figure 13. Global Covid-19 Rapid Antigen Average Price (US$/Unit) & (2020-2031)
 Figure 14. Covid-19 Rapid Antigen Report Years Considered
 Figure 15. Covid-19 Rapid Antigen Sales Share by Manufacturers in 2024
 Figure 16. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Covid-19 Rapid Antigen Players: Market Share by Revenue in Covid-19 Rapid Antigen in 2024
 Figure 18. Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Covid-19 Rapid Antigen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Covid-19 Rapid Antigen Sales Market Share by Country (2020-2031)
 Figure 21. North America Covid-19 Rapid Antigen Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Covid-19 Rapid Antigen Sales Market Share by Country (2020-2031)
 Figure 25. Europe Covid-19 Rapid Antigen Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Covid-19 Rapid Antigen Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Covid-19 Rapid Antigen Revenue Market Share by Region (2020-2031)
 Figure 33. China Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Covid-19 Rapid Antigen Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Covid-19 Rapid Antigen Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Covid-19 Rapid Antigen Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Covid-19 Rapid Antigen Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Covid-19 Rapid Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Covid-19 Rapid Antigen by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Covid-19 Rapid Antigen by Type (2020-2031)
 Figure 55. Global Covid-19 Rapid Antigen Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Covid-19 Rapid Antigen by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Covid-19 Rapid Antigen by Application (2020-2031)
 Figure 58. Global Covid-19 Rapid Antigen Price (US$/Unit) by Application (2020-2031)
 Figure 59. Covid-19 Rapid Antigen Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Rapid Covid 19 Antigen Test Kit Market Research Report 2025
Global Rapid Antigen Testing RAT for COVID 19 Market Research Report 2025
Global COVID 19 Antigen Detection Kit Market Research Report 2025
Global COVID 19 Antibody Rapid Test Kits Market Research Report 2025
Global COVID 19 Antigen Detection Reagent Market Research Report 2025
Global Antigen COVID 19 Testing Service Market Research Report 2024
Global COVID 19 Antigen Self Test Market Research Report 2024
Global COVID 19 Rapid Diagnostic Test Kit Market Research Report 2025
Global COVID 19 Antigen Testing Devices Market Research Report 2025
Global Antigen Rapid Test Market Research Report 2025
Global Rapid Antigen Testing Market Research Report 2024
Global COVID 19 Antigen Self Test Kits Market Research Report 2025
Covid 19 Rapid Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Covid 19 Antibody Test Market Research Report 2024
Global Rapid COVID 19 Testing Devices Market Research Report 2024
Global COVID 19 IgM IgG Antibody Rapid Test Kits Market Research Report 2024
Global COVID 19 Antigen Kit Market Research Report 2024
Global Adenovirus Antigen Rapid Tests Market Research Report 2025
Global COVID 19 Antigen Rapid Test Kits Market Research Report 2025
Global COVID 19 Rapid Antigen Test Kits Market Research Report 2025

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions